Detalhe da pesquisa
1.
Development of a Prognostic Model for Early Breast Cancer Integrating Neutrophil to Lymphocyte Ratio and Clinical-Pathological Characteristics.
Oncologist;
29(4): e447-e454, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37971409
2.
Hedgehog Inhibitors Beyond Clinical Complete Response in Basal Cell Carcinoma: Should I Stop or Should I Go?
Oncologist;
29(5): e699-e707, 2024 May 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38127280
3.
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection.
J Transl Med;
22(1): 70, 2024 Jan 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38233934
4.
Comprehensive genomic profiling on metastatic Melanoma: results from a network screening from 7 Italian Cancer Centres.
J Transl Med;
22(1): 29, 2024 Jan 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38184610
5.
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol;
24(12): e461-e471, 2023 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37459873
6.
Melanoma-derived soluble mediators modulate neutrophil biological properties and the release of neutrophil extracellular traps.
Cancer Immunol Immunother;
72(10): 3363-3376, 2023 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37525065
7.
IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab.
J Transl Med;
21(1): 140, 2023 02 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36823670
8.
CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy.
J Transl Med;
21(1): 610, 2023 09 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37684649
9.
Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned.
Curr Oncol Rep;
25(6): 623-634, 2023 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36995534
10.
Clinical Characteristics of an Italian Patient Population with Advanced BCC and Real-Life Evaluation of Hedgehog Pathway Inhibitor Safety and Effectiveness.
Dermatology;
239(6): 868-876, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37311439
11.
Atezolizumab, vemurafenib, and cobimetinib in patients with melanoma with CNS metastases (TRICOTEL): a multicentre, open-label, single-arm, phase 2 study.
Lancet Oncol;
23(9): 1145-1155, 2022 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35940183
12.
Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma.
J Transl Med;
20(1): 159, 2022 04 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35382857
13.
Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization.
J Transl Med;
20(1): 436, 2022 09 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36180872
14.
Management of cutaneous melanoma: radiologists challenging and risk assessment.
Radiol Med;
127(8): 899-911, 2022 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35834109
15.
Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.
Int J Cancer;
149(11): 1926-1934, 2021 12 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34310716
16.
Immunotherapy may protect cancer patients from SARS-CoV-2 infection: a single-center retrospective analysis.
J Transl Med;
19(1): 132, 2021 03 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33789686
17.
Avelumab treatment in Italian patients with metastatic Merkel cell carcinoma: experience from an expanded access program.
J Transl Med;
19(1): 70, 2021 02 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33588870
18.
Emerging PD-1/PD-L1 antagonists for the treatment of malignant melanoma.
Expert Opin Emerg Drugs;
26(2): 79-92, 2021 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33686894
19.
Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
J Transl Med;
18(1): 405, 2020 10 21.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33087150
20.
MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors.
Int J Mol Sci;
21(12)2020 Jun 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32604720